GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirtex Medical Ltd (GREY:SRXTY) » Definitions » Profitability Rank

Sirtex Medical (Sirtex Medical) Profitability Rank : 0 (As of Jun. 2018)


View and export this data going back to 2015. Start your Free Trial

What is Sirtex Medical Profitability Rank?

Sirtex Medical has the Profitability Rank of 0.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Sirtex Medical's Operating Margin % for the quarter that ended in Jun. 2018 was -49.48%. As of today, Sirtex Medical's Piotroski F-Score is 7.


Competitive Comparison of Sirtex Medical's Profitability Rank

For the Biotechnology subindustry, Sirtex Medical's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirtex Medical's Profitability Rank Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirtex Medical's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Sirtex Medical's Profitability Rank falls into.



Sirtex Medical Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Sirtex Medical has the Profitability Rank of 0.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Sirtex Medical's Operating Margin % for the quarter that ended in Jun. 2018 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2018 ) / Revenue (Q: Jun. 2018 )
=-40.552 / 81.963
=-49.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

Good Sign:

Piotroski F-Score of 7 is 7, indicating very healthy situation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Sirtex Medical has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

Warning Sign:

Sirtex Medical Ltd operating margin has been in 5-year decline. The average rate of decline per year is -1.8%.

4. Consistency of the profitability

5. Predictability Rank


Sirtex Medical Profitability Rank Related Terms

Thank you for viewing the detailed overview of Sirtex Medical's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirtex Medical (Sirtex Medical) Business Description

Traded in Other Exchanges
N/A
Address
Sirtex Medical is an Australian oncology-focused medical device company with a novel embolic radiation therapy device, which is currently used as salvage therapy in the treatment of inoperable liver cancer. Sirtex's key product is SIR-Spheres microspheres, which utilise extremely small resin beads containing radioactive yttrium-90. SIR-Spheres are designed, manufactured, and distributed by Sirtex for approved markets in Asia-Pacific; Europe, Middle East, and Africa, or EMEA; and North America.

Sirtex Medical (Sirtex Medical) Headlines

No Headlines